 | • レポートコード：GIR-23F3796 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Drugs for Musculoskeletal Disorders Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の筋骨格系疾患治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 筋骨格系疾患治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・OTC、Rxドラッグ アプリケーション別セグメントは次のように区分されます。 ・病院、薬局 世界の筋骨格系疾患治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・AbbVie、Amgen、Johnson & Johnson、Roche、Pfizer Inc、Eli Lilly 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 筋骨格系疾患治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：OTC、Rxドラッグ - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局 - 世界の筋骨格系疾患治療薬市場規模・予測 - 世界の筋骨格系疾患治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AbbVie、Amgen、Johnson & Johnson、Roche、Pfizer Inc、Eli Lilly ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：OTC、Rxドラッグ ・アプリケーション別分析2017年-2028年：病院、薬局 ・筋骨格系疾患治療薬の北米市場分析 - 筋骨格系疾患治療薬の北米市場：タイプ別市場規模2017年-2028年 - 筋骨格系疾患治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・筋骨格系疾患治療薬のヨーロッパ市場分析 - ：筋骨格系疾患治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：筋骨格系疾患治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・筋骨格系疾患治療薬のアジア太平洋市場分析 - 筋骨格系疾患治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 筋骨格系疾患治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・筋骨格系疾患治療薬の南米市場分析 - 筋骨格系疾患治療薬の南米市場：タイプ別市場規模2017年-2028年 - 筋骨格系疾患治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・筋骨格系疾患治療薬の中東・アフリカ市場分析 - 筋骨格系疾患治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 筋骨格系疾患治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drugs for Musculoskeletal Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drugs for Musculoskeletal Disorders market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Drugs for Musculoskeletal Disorders global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While OTC segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drugs for Musculoskeletal Disorders include AbbVie, Amgen, Johnson & Johnson, Roche, and Pfizer Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drugs for Musculoskeletal Disorders market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
OTC
Rx Drugs
Market segment by Application can be divided into
Hospital
Retail Pharmacy
The key market players for global Drugs for Musculoskeletal Disorders market are listed below:
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Musculoskeletal Disorders product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Musculoskeletal Disorders, with price, sales, revenue and global market share of Drugs for Musculoskeletal Disorders from 2019 to 2022.
Chapter 3, the Drugs for Musculoskeletal Disorders competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Musculoskeletal Disorders breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drugs for Musculoskeletal Disorders market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Musculoskeletal Disorders.
Chapter 13, 14, and 15, to describe Drugs for Musculoskeletal Disorders sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Drugs for Musculoskeletal Disorders Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Musculoskeletal Disorders Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Musculoskeletal Disorders Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Drugs for Musculoskeletal Disorders Market Size & Forecast
1.4.1 Global Drugs for Musculoskeletal Disorders Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Musculoskeletal Disorders Sales in Volume (2017-2028)
1.4.3 Global Drugs for Musculoskeletal Disorders Price (2017-2028)
1.5 Global Drugs for Musculoskeletal Disorders Production Capacity Analysis
1.5.1 Global Drugs for Musculoskeletal Disorders Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Musculoskeletal Disorders Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Musculoskeletal Disorders Market Drivers
1.6.2 Drugs for Musculoskeletal Disorders Market Restraints
1.6.3 Drugs for Musculoskeletal Disorders Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Drugs for Musculoskeletal Disorders Product and Services
2.1.4 AbbVie Drugs for Musculoskeletal Disorders Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Drugs for Musculoskeletal Disorders Product and Services
2.2.4 Amgen Drugs for Musculoskeletal Disorders Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Drugs for Musculoskeletal Disorders Product and Services
2.3.4 Johnson & Johnson Drugs for Musculoskeletal Disorders Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Drugs for Musculoskeletal Disorders Product and Services
2.4.4 Roche Drugs for Musculoskeletal Disorders Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer Inc
2.5.1 Pfizer Inc Details
2.5.2 Pfizer Inc Major Business
2.5.3 Pfizer Inc Drugs for Musculoskeletal Disorders Product and Services
2.5.4 Pfizer Inc Drugs for Musculoskeletal Disorders Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Drugs for Musculoskeletal Disorders Product and Services
2.6.4 Eli Lilly Drugs for Musculoskeletal Disorders Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Musculoskeletal Disorders Breakdown Data by Manufacturer
3.1 Global Drugs for Musculoskeletal Disorders Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Musculoskeletal Disorders Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Musculoskeletal Disorders
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Musculoskeletal Disorders Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Musculoskeletal Disorders Manufacturer Market Share in 2021
3.5 Global Drugs for Musculoskeletal Disorders Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Musculoskeletal Disorders Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Musculoskeletal Disorders Market Size by Region
4.1.1 Global Drugs for Musculoskeletal Disorders Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Musculoskeletal Disorders Revenue by Region (2017-2028)
4.2 North America Drugs for Musculoskeletal Disorders Revenue (2017-2028)
4.3 Europe Drugs for Musculoskeletal Disorders Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Musculoskeletal Disorders Revenue (2017-2028)
4.5 South America Drugs for Musculoskeletal Disorders Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Musculoskeletal Disorders Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Musculoskeletal Disorders Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Musculoskeletal Disorders Revenue by Type (2017-2028)
5.3 Global Drugs for Musculoskeletal Disorders Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Musculoskeletal Disorders Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Musculoskeletal Disorders Revenue by Application (2017-2028)
6.3 Global Drugs for Musculoskeletal Disorders Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
7.2 North America Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
7.3 North America Drugs for Musculoskeletal Disorders Market Size by Country
7.3.1 North America Drugs for Musculoskeletal Disorders Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
8.2 Europe Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
8.3 Europe Drugs for Musculoskeletal Disorders Market Size by Country
8.3.1 Europe Drugs for Musculoskeletal Disorders Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Musculoskeletal Disorders Market Size by Region
9.3.1 Asia-Pacific Drugs for Musculoskeletal Disorders Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Musculoskeletal Disorders Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
10.2 South America Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
10.3 South America Drugs for Musculoskeletal Disorders Market Size by Country
10.3.1 South America Drugs for Musculoskeletal Disorders Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Musculoskeletal Disorders Market Size by Country
11.3.1 Middle East & Africa Drugs for Musculoskeletal Disorders Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Musculoskeletal Disorders Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Musculoskeletal Disorders and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Musculoskeletal Disorders
12.3 Drugs for Musculoskeletal Disorders Production Process
12.4 Drugs for Musculoskeletal Disorders Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Musculoskeletal Disorders Typical Distributors
13.3 Drugs for Musculoskeletal Disorders Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Drugs for Musculoskeletal Disorders Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Musculoskeletal Disorders Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Drugs for Musculoskeletal Disorders Product and Services
Table 6. AbbVie Drugs for Musculoskeletal Disorders Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Drugs for Musculoskeletal Disorders Product and Services
Table 10. Amgen Drugs for Musculoskeletal Disorders Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Drugs for Musculoskeletal Disorders Product and Services
Table 14. Johnson & Johnson Drugs for Musculoskeletal Disorders Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Drugs for Musculoskeletal Disorders Product and Services
Table 18. Roche Drugs for Musculoskeletal Disorders Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc Major Business
Table 21. Pfizer Inc Drugs for Musculoskeletal Disorders Product and Services
Table 22. Pfizer Inc Drugs for Musculoskeletal Disorders Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Drugs for Musculoskeletal Disorders Product and Services
Table 26. Eli Lilly Drugs for Musculoskeletal Disorders Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Drugs for Musculoskeletal Disorders Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Drugs for Musculoskeletal Disorders Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Drugs for Musculoskeletal Disorders, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Drugs for Musculoskeletal Disorders Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Drugs for Musculoskeletal Disorders Production Site of Key Manufacturer
Table 32. Drugs for Musculoskeletal Disorders New Entrant and Capacity Expansion Plans
Table 33. Drugs for Musculoskeletal Disorders Mergers & Acquisitions in the Past Five Years
Table 34. Global Drugs for Musculoskeletal Disorders Sales by Region (2017-2022) & (K Units)
Table 35. Global Drugs for Musculoskeletal Disorders Sales by Region (2023-2028) & (K Units)
Table 36. Global Drugs for Musculoskeletal Disorders Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Drugs for Musculoskeletal Disorders Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Drugs for Musculoskeletal Disorders Sales by Type (2017-2022) & (K Units)
Table 39. Global Drugs for Musculoskeletal Disorders Sales by Type (2023-2028) & (K Units)
Table 40. Global Drugs for Musculoskeletal Disorders Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Drugs for Musculoskeletal Disorders Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Drugs for Musculoskeletal Disorders Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Drugs for Musculoskeletal Disorders Price by Type (2023-2028) & (USD/Unit)
Table 44. Global Drugs for Musculoskeletal Disorders Sales by Application (2017-2022) & (K Units)
Table 45. Global Drugs for Musculoskeletal Disorders Sales by Application (2023-2028) & (K Units)
Table 46. Global Drugs for Musculoskeletal Disorders Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Drugs for Musculoskeletal Disorders Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Drugs for Musculoskeletal Disorders Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Drugs for Musculoskeletal Disorders Price by Application (2023-2028) & (USD/Unit)
Table 50. North America Drugs for Musculoskeletal Disorders Sales by Country (2017-2022) & (K Units)
Table 51. North America Drugs for Musculoskeletal Disorders Sales by Country (2023-2028) & (K Units)
Table 52. North America Drugs for Musculoskeletal Disorders Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Drugs for Musculoskeletal Disorders Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Drugs for Musculoskeletal Disorders Sales by Type (2017-2022) & (K Units)
Table 55. North America Drugs for Musculoskeletal Disorders Sales by Type (2023-2028) & (K Units)
Table 56. North America Drugs for Musculoskeletal Disorders Sales by Application (2017-2022) & (K Units)
Table 57. North America Drugs for Musculoskeletal Disorders Sales by Application (2023-2028) & (K Units)
Table 58. Europe Drugs for Musculoskeletal Disorders Sales by Country (2017-2022) & (K Units)
Table 59. Europe Drugs for Musculoskeletal Disorders Sales by Country (2023-2028) & (K Units)
Table 60. Europe Drugs for Musculoskeletal Disorders Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Drugs for Musculoskeletal Disorders Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Drugs for Musculoskeletal Disorders Sales by Type (2017-2022) & (K Units)
Table 63. Europe Drugs for Musculoskeletal Disorders Sales by Type (2023-2028) & (K Units)
Table 64. Europe Drugs for Musculoskeletal Disorders Sales by Application (2017-2022) & (K Units)
Table 65. Europe Drugs for Musculoskeletal Disorders Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Drugs for Musculoskeletal Disorders Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Drugs for Musculoskeletal Disorders Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Drugs for Musculoskeletal Disorders Sales by Application (2023-2028) & (K Units)
Table 74. South America Drugs for Musculoskeletal Disorders Sales by Country (2017-2022) & (K Units)
Table 75. South America Drugs for Musculoskeletal Disorders Sales by Country (2023-2028) & (K Units)
Table 76. South America Drugs for Musculoskeletal Disorders Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Drugs for Musculoskeletal Disorders Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Drugs for Musculoskeletal Disorders Sales by Type (2017-2022) & (K Units)
Table 79. South America Drugs for Musculoskeletal Disorders Sales by Type (2023-2028) & (K Units)
Table 80. South America Drugs for Musculoskeletal Disorders Sales by Application (2017-2022) & (K Units)
Table 81. South America Drugs for Musculoskeletal Disorders Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Drugs for Musculoskeletal Disorders Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Drugs for Musculoskeletal Disorders Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Drugs for Musculoskeletal Disorders Sales by Application (2023-2028) & (K Units)
Table 90. Drugs for Musculoskeletal Disorders Raw Material
Table 91. Key Manufacturers of Drugs for Musculoskeletal Disorders Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Drugs for Musculoskeletal Disorders Typical Distributors
Table 95. Drugs for Musculoskeletal Disorders Typical Customers
List of Figures
Figure 1. Drugs for Musculoskeletal Disorders Picture
Figure 2. Global Drugs for Musculoskeletal Disorders Revenue Market Share by Type in 2021
Figure 3. OTC
Figure 4. Rx Drugs
Figure 5. Global Drugs for Musculoskeletal Disorders Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Retail Pharmacy
Figure 8. Global Drugs for Musculoskeletal Disorders Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Drugs for Musculoskeletal Disorders Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Drugs for Musculoskeletal Disorders Sales (2017-2028) & (K Units)
Figure 11. Global Drugs for Musculoskeletal Disorders Price (2017-2028) & (USD/Unit)
Figure 12. Global Drugs for Musculoskeletal Disorders Production Capacity (2017-2028) & (K Units)
Figure 13. Global Drugs for Musculoskeletal Disorders Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Drugs for Musculoskeletal Disorders Market Drivers
Figure 15. Drugs for Musculoskeletal Disorders Market Restraints
Figure 16. Drugs for Musculoskeletal Disorders Market Trends
Figure 17. Global Drugs for Musculoskeletal Disorders Sales Market Share by Manufacturer in 2021
Figure 18. Global Drugs for Musculoskeletal Disorders Revenue Market Share by Manufacturer in 2021
Figure 19. Drugs for Musculoskeletal Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Drugs for Musculoskeletal Disorders Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Drugs for Musculoskeletal Disorders Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Drugs for Musculoskeletal Disorders Sales Market Share by Region (2017-2028)
Figure 23. Global Drugs for Musculoskeletal Disorders Revenue Market Share by Region (2017-2028)
Figure 24. North America Drugs for Musculoskeletal Disorders Revenue (2017-2028) & (USD Million)
Figure 25. Europe Drugs for Musculoskeletal Disorders Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Drugs for Musculoskeletal Disorders Revenue (2017-2028) & (USD Million)
Figure 27. South America Drugs for Musculoskeletal Disorders Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Drugs for Musculoskeletal Disorders Revenue (2017-2028) & (USD Million)
Figure 29. Global Drugs for Musculoskeletal Disorders Sales Market Share by Type (2017-2028)
Figure 30. Global Drugs for Musculoskeletal Disorders Revenue Market Share by Type (2017-2028)
Figure 31. Global Drugs for Musculoskeletal Disorders Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
Figure 33. Global Drugs for Musculoskeletal Disorders Revenue Market Share by Application (2017-2028)
Figure 34. Global Drugs for Musculoskeletal Disorders Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Drugs for Musculoskeletal Disorders Sales Market Share by Type (2017-2028)
Figure 36. North America Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
Figure 37. North America Drugs for Musculoskeletal Disorders Sales Market Share by Country (2017-2028)
Figure 38. North America Drugs for Musculoskeletal Disorders Revenue Market Share by Country (2017-2028)
Figure 39. United States Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Drugs for Musculoskeletal Disorders Sales Market Share by Type (2017-2028)
Figure 43. Europe Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
Figure 44. Europe Drugs for Musculoskeletal Disorders Sales Market Share by Country (2017-2028)
Figure 45. Europe Drugs for Musculoskeletal Disorders Revenue Market Share by Country (2017-2028)
Figure 46. Germany Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Drugs for Musculoskeletal Disorders Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Drugs for Musculoskeletal Disorders Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drugs for Musculoskeletal Disorders Revenue Market Share by Region (2017-2028)
Figure 55. China Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Drugs for Musculoskeletal Disorders Sales Market Share by Type (2017-2028)
Figure 62. South America Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
Figure 63. South America Drugs for Musculoskeletal Disorders Sales Market Share by Country (2017-2028)
Figure 64. South America Drugs for Musculoskeletal Disorders Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Drugs for Musculoskeletal Disorders Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Drugs for Musculoskeletal Disorders Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Drugs for Musculoskeletal Disorders Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Drugs for Musculoskeletal Disorders Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Drugs for Musculoskeletal Disorders Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Drugs for Musculoskeletal Disorders in 2021
Figure 76. Manufacturing Process Analysis of Drugs for Musculoskeletal Disorders
Figure 77. Drugs for Musculoskeletal Disorders Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
• 日本語訳：筋骨格系疾患治療薬のグローバル市場2022年
• レポートコード：GIR-23F3796 ▷ お問い合わせ（見積依頼・ご注文・質問）